Cardiome Pharma Corp (NASDAQ:CRME)

1.47
Delayed Data
As of Feb 16
 +0.04 / +2.80%
Today’s Change
1.29
Today|||52-Week Range
4.84
-5.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues7.0M5.2M5.8M6.0M
 
 
 
 
 
Cost of Goods Sold1.9M1.6M1.7M1.5M
 
 
 
 
 
Depreciation And Amortization853.0K835.0K842.0K890.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.3M2.7M3.2M3.6M
 
 
 
 
 
General Expenses9.1M8.2M9.6M8.5M
 
 
 
 
 
Total Operating Expenses11.8M10.7M12.1M10.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.8M-5.5M-6.4M-4.8M
 
 
 
 
 
Extraordinary Charge0.000.00-1.4M-29.0K
 
 
 
Interest Expense On Debt828.0K787.0K1.2M1.8M
 
 
 
 
 
Other Expenses-41.0K-11.0K530.0K80.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-6.3M-8.5M-6.5M
 
 
 
 
 
Income Taxes-73.0K-43.0K-12.0K-74.0K
 
 
 
 
 
Net Income-5.6M-6.3M-8.5M-6.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.9M31.9M32.4M33.8M
 
 
 
 
 
Shares To Calculate EPS Diluted31.9M31.9M32.4M33.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.20-$0.26-$0.20
 
 
 
 
 
EPS Diluted-$0.18-$0.20-$0.26-$0.20